Últimas noticias sobre Super Group (SGHC) (NYSE:SGHC) Bolsa

Super Group (SGHC)

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

Super Group (SGHC) Limited Ordinary Shares

Super Group (SGHC) Ltd

RBC Capital analyst Deane Dray maintains Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) with a Sector Perform and raises the price target from $78 to $79.

News

Price Target

Analyst Ratings

RBC Capital Maintains Sector Perform on Fortive, Raises Price Target to $79

WIIM

Gerdau shares are trading higher after UBS upgraded its rating on the stock from Neutral to Buy and raised the price target from $2.9 to $3.8.

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Buy and raises the price target from $65 to $75.

Chardan Capital Maintains Buy on Avidity Biosciences, Raises Price Target to $75

MBOT

Microbot Medical shares are trading lower. The company announced the continued expansion of its commercial team in preparation for the anticipated U.S. launch of the LIBERTY System.

This summer, 53% of Americans plan to take leisure summer vacations, up from 48% in 2024, according to a new <a href="https://www2.deloitte.com/content/dam/insights/articles/us188222_summer-travel-2025/DI_2025-Summer-Travel.pdf">report</a> from Deloitte.&nbsp;
Deloitte conducted two rounds of the survey, one in late March before President Donald Trump's new tariffs were announced, and one in mid-April after the tariffs were set. While plans in some areas remained the same, like how many trips Americans planned to take and how long those trips were going to be, the second round of surveys found that Americans were planning to spend less on their vacations in light of recession fears.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.</li>
</ul>
Initially, the annual summer travel budget was expected to grow 21% year over year, to $4,967. In the second round, however, travelers said they only planned to spend $4,606 on vacations, up 13% from last year.
Additionally, planned spending on marquee trips, those that are either bucket list items or intended to mark a specific occasion, shrank from $3,987 per trip to $3,417, just a 1% increase from last year.
"We still see a strong summer travel season, but perhaps with a more frugal approach," Deloitte's transportation, hospitality and services sector leader, Kate Ferrara, told <a href="https://www.cnbc.com/2025/05/31/how-to-save-on-summer-travel-in-2025.html">CNBC</a>,&nbsp;
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Those surveyed reported that they planned to alter trip length, in-destination spending, lodging type, and airfare class to make their trips more budget-friendly. For example, the average number of trips respondents have planned this summer is 3.1, but quick getaways of three nights or less comprise a large number of those planned vacations. In the same vein, 24% of travelers plan to stay with family or friends while on vacation, and 19% plan to drive to their destinations rather than take a flight.&nbsp;
"The root of all of our hacks for saving this summer is flexibility," lead economist at travel site Hopper Hailey Berg told CNBC.&nbsp;
Planned travel spending is also not equal across all income levels and generations, Deloitte found. Those who make over $100,000 now account for 49% of vacationers, up from 44% in 2024. Middle-income earners, who make between $50,000 and $100,000 each year, have shrunk from 37% of vacationers to 33%, while those who make under $50,000 have stayed largely the same, declining just 1% from 19% to 18%.
Millennials and Gen Xers make up roughly the same share of summer travelers as last year, 29% and 24% respectively, while the number of Gen Zers has increased as boomers begin to slow down, according to the survey.
Read Next:
<ul class="wp-block-list">
<li>Wall Street's Missing This AI Surgical Tech — You Don't Have To.<a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution"> Invest from $350.</a></li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

Personal Finance

Travelers Plan To Spend $4,600 On Vacations This Summer, Up 16% From 2024

Craig-Hallum analyst Chase Knickerbocker maintains Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) with a Buy and raises the price target from $12 to $17.

PHAT

Craig-Hallum Maintains Buy on Phathom Pharmaceuticals, Raises Price Target to $17

First-of-its-kind integration gives hotels the ability to offer in-house guests priority access to OpenTable reservations and experiences via UrVenue's Itinerary Builder; Visit UrVenue at HITEC Indianapolis June 17 to 19 in Booth #1100
LAS VEGAS, June 9, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445043-1&amp;h=3958839253&amp;u=http%3A%2F%2Fwww.urvenue.com%2F&amp;a=UrVenue">UrVenue</a>, the leading booking technology provider for hospitality experiences, today announced an expanded partnership with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445043-1&amp;h=1701976961&amp;u=http%3A%2F%2Fwww.opentable.com%2F&amp;a=OpenTable">OpenTable</a>, a global leader in restaurant technology.
Building on their <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445043-1&amp;h=1780976184&amp;u=https%3A%2F%2Fwww.urvenue.com%2Fnews%2Fopentable-and-urvenue-partner-to-launch-a-unified-solution-for-booking-resort-experiences%2F&amp;a=successful+2021+integration">successful 2021 integration</a> – which unified dining reservations with resort activities – this expanded collaboration gives hotels the ability to offer&nbsp;guests, both those that are already on-property and with upcoming stays, priority access to premium OpenTable reservations directly through UrVenue's <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4445043-1&amp;h=2133595740&amp;u=https%3A%2F%2Fwww.urvenue.com%2Fnews%2Fintroducing-urvenues-itinerary-builder-a-unified-booking-solution-for-experience-based-inventory%2F&amp;a=Itinerary+Builder">Itinerary Builder</a> as part of the pre-arrival journey. Guests can secure exclusive, high-demand restaurant bookings and curated dining events in advance, while hotel staff can also manage reservations on their behalf through UrVenue's Experience Center, ensuring seamless, personalized service.

BKNG

UrVenue Expands Partnership With Booking Holdings' OpenTable To Unlock Access To Premium Restaurant Reservations For Hotel Guests

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09114736/Dazhong.jpeg" alt="" class="wp-image-14102" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09114736/Dazhong.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09114736/Dazhong-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/09114736/Dazhong-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The company has filed to list in Hong Kong, aiming to jumpstart its falling revenue and profits by buying up rivals in China's fragmented dental services market
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Dazhong Dental has filed to list in Hong Kong, aiming to attract investors with its status as China's fifth-largest dental services provider by revenue and third-largest by profit</li>
<li>The company's lackluster performance last year was mainly due to falling customer visits, but it could benefit from M&amp;A opportunities as the industry consolidates</li>
</ul>
China's economic slowdown is wiping the smile from the face of&nbsp;Wuhan Dazhong Dental Medical Co. Ltd., as increasingly cautious consumers rein in their spending on services like tooth whitening and other oral procedures considered relatively discretionary. But that hasn't stopped the company from seizing on a recent wave of IPO fever in Hong Kong, as it tries to sell itself as a future consolidator in China's highly fragmented dental services sector. &nbsp;&nbsp;&nbsp;
Dazhong is a relative old-timer on China's dental scene, established by Zhongshan Medical Investment in 2007 before being restructured into a joint stock company seven years later, according to its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107406/documents/sehk25052900245.pdf">listing application</a>&nbsp;filed late last month. It was planning to list on China's thinly traded National Equities Exchange and Quotations (NEEQ) board in 2018 but changed its mind due to limited trading volumes, and has now shifted its sights to Hong Kong.
China's dental services market is massive, worth 141.8 billion yuan ($19.7 billion) in 2019. But growth has largely stalled since then, partly due to the pandemic and a slow post-pandemic recovery. Since 2019, the market has only grown 1.9% to reach 144.6 billion yuan last year. Recent government policy measures to boost consumption have been providing some indirect relief to the market, which is expected to resume growing at an average rate of 6% from 2023 to reach 193.2 billion yuan in 2028.
The Chinese dental services market includes a mix of both public and private service providers. Public facilities are cheaper but lack flexibility and often require long waits. That has allowed private clinics, which typically charge more, to build a clientele by targeting people who want shorter waits and more customized services. In 2023, private dental service providers already accounted for 92% of the Chinese market.
Dazhong Dental had 701 dental chairs in 2023, making it China's fifth-largest private dental services provider, according to third-party market data cited in the listing document. The company ranked third in the industry based on the size of its profit.
Dazhong breaks down its business into three major segments: general dentistry, implantology and orthodontics services, accounting for 53.4%, 28.4% and 18.2% of its revenue in 2024, respectively. Revenue for all three segments fell last year as China's post-pandemic rebound ran out of steam, resulting in a 7.9% annual revenue decline to 407 million yuan, and an even larger 16.3% drop in net profit to 41.92 million yuan from 2023.
Services charges under pressure
The company blamed its weak performance last year on the government's growing shift to centralized procurement policies in the medical sector, and to tighter price regulation over the dental services market. Overall procurement costs for the company's implantology business dropped 15% last year from 2023. But policy-driven price reductions, compounded by cutthroat competition, drove down Dazhong's implantology service charges between 25% and 40%, more than offsetting the drop in costs.
At the same time, the company's total customer visits also declined 2.6% to 749,000 last year from 769,000 in 2023, contributing to its lackluster performance. The company blamed the decline on renovations for three of its clinics in Wuhan and the expiry of leases for some of its medical centers, including eight that moved out of its home city of Wuhan. By May 20, the company had 62 medical institutions, down by three from 2024.
Dazhong isn't the only private dental company feeling such pains, and believes it is well-positioned to benefit from better dental resource allocation and improved brand recognition that will help it return to customer growth. In addition to boasting better economies of scale than many of its rivals due to its relatively large size, the company said it is also confident of its ability to navigate the policy changes that are squeezing its profits.
Strong M&amp;A prospects
Despite the many short-term headwinds they now face, China's dental services providers may face better prospects over the longer haul. In addition to growing demand from an aging population and growing emphasis on dental health, the current fragmented state of the market also makes it ripe for consolidation. Only 3% of China's dental service providers currently operate chains, and the combined share of the top five companies is less than 10% of the market, highlighting the potential for M&amp;A.
What's more, Dazhong's focus is on the relatively underserved Central China region, with its presence concentrated in Hubei, Hunan, Henan and Jiangxi provinces. While Central China accounts for around 19% of China's total population, it has just 184 dentists per million people, far less than the national average of 269. As a regional leader in dental services, Dazhong Dental stands to directly benefit from the growing demand for dentistry services as the Central China region plays catchup with the rest of the country.
Most medical service providers aren't too affected by seasonal factors, but the same isn't true for dental services. The summer school holidays in July and August are a strong period as parents have more time to bring in their children and teenagers for treatment of dental problems and teeth cleaning, making the third quarter of each year relatively strong. By contrast, customer flows taper off during the Lunar New Year holiday as customers relax and put off treatment, translating to lower revenue in the first quarter.
Only a few dental services companies are currently listed in Hong Kong, Shanghai and Shenzhen, including Shanghai-listed&nbsp;Topchoice Medical&nbsp;(600763.SH) and Hong Kong-listed&nbsp;Arrail Group&nbsp;(6639.HK). The two are relatively highly valued, with the former trading at a forward price-to-earnings (P/E) ratio of 33.5 times while the latter trades at 50.5 times.
If it makes it to market, Dazhong's stock could be lifted by a number of factors in its favor, most notably some of the strongest sentiment in years towards new listings in Hong Kong. Investors may also like the company's story of being a potential market consolidator. But there are also downside risks, most notably the company's falling business metrics and ongoing pressure from central government procurement programs and price-setting policies. If the company can convince investors it can navigate those factors, it could end up all smiles when it finally makes its trading debut.

Asia

IPOs

Opinion

Dazhong Dental Files For Hong Kong IPO

Craig-Hallum analyst Jason Kreyer reinstates TechTarget (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) with a Buy and announces $12 price target.

Initiation

TTGT

Craig-Hallum Reinstates Buy on TechTarget, Announces $12 Price Target

Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) has outperformed the market over the past 10 years by 4.74% on an annualized basis producing an average annual return of 15.8%. Currently, Chipotle Mexican Grill has a market capitalization of $70.16 billion. 
Buying $100 In CMG: If an investor had bought $100 of CMG stock 10 years ago, it would be worth $430.92 today based on a price of $52.07 for CMG at the time of writing.
<h3>Chipotle Mexican Grill's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749480314_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

B of A Securities analyst Ken Hoexter maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Underperform and lowers the price target from $67 to $63.

ARCB

B of A Securities Maintains Underperform on ArcBest, Lowers Price Target to $63

D. Boral Capital analyst Jason Kolbert maintains Citius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) with a Buy and maintains $9 price target.

CTXR

D. Boral Capital Maintains Buy on Citius Pharmaceuticals, Maintains $9 Price Target

KLTO

Klotho Neurosciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 636.6%

707 Cayman Holdings Limited ("707" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEM#NASDAQ">JEM</a>), a Hong Kong-based company that sells quality apparel products and provides supply chain management total solutions, today announced the pricing of its initial public offering (the "Offering") of an aggregate 2,500,000 ordinary shares at a public offering price of $4.00 per share for total gross proceeds of $10.0 million, before deducting underwriting discounts and offering expenses. The Company is offering 1,750,000 ordinary shares and the selling shareholder is offering in aggregate 750,000 ordinary shares. The Company will not receive any proceeds from any sale of shares by the selling shareholder.
The shares are scheduled to begin trading on the Nasdaq Capital Market on June 9, 2025, under the ticker symbol "JEM." The Offering is expected to close on or about June 10, 2025, subject to customary closing conditions.

707 Cayman Holdings Prices IPO Of Aggregate 2.50M Ordinary Shares At $4.00/Shr For Total Gross Proceeds Of $10M

ONDS

Ondas Holdings shares are trading higher after the company announced it secured a $14.3 million order from a defense customer for multiple units of its Optimus System.

B of A Securities analyst Craig Siegenthaler initiates coverage on Etoro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETOR#NASDAQ">ETOR</a>) with a Neutral rating and announces Price Target of $71.

ETOR

B of A Securities Initiates Coverage On Etoro Group with Neutral Rating, Announces Price Target of $71

D. Boral Capital analyst Jason Kolbert maintains Humacyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) with a Buy and maintains $25 price target.

HUMA

D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target

MPAA

Motorcar Parts of America shares are trading lower after the company reported Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.

B of A Securities analyst Tal Liani maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy and raises the price target from $285 to $340.

B of A Securities Maintains Buy on Zscaler, Raises Price Target to $340

Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) announced Monday an <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45833444/plug-power-and-allied-green-expand-strategic-collaboration-with-new-2-gw-electrolyzer-deal-in-uzbe" rel="noreferrer noopener">expanded partnership</a> with Allied Green Ammonia (AGA), adding a 2-gigawatt electrolyzer agreement for a $5.5 billion sustainable fuels project in Uzbekistan.
The deal will be signed during the Tashkent International Investment Forum, with senior leaders from both companies in attendance.
The Uzbekistan facility builds on Allied Green&#8217;s earlier 3 GW electrolyzer commitment for its green ammonia plant in Australia.
The company said in a press release that the two projects represent 5 GW of electrolyzer capacity across continents, reinforcing Plug&#8217;s role in large-scale decarbonization efforts.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45679693/plug-powers-record-hydrogen-output-in-georgia-signals-growth-potential" rel="noreferrer noopener">Plug Power&#8217;s Record Hydrogen Output In Georgia Signals Growth Potential</a>
Plug&#8217;s electrolyzer systems will power the Uzbekistan plant, which aims to produce green urea, sustainable aviation fuel, and green diesel. Backed by the Uzbek government, the project highlights the growing global demand for clean fuel solutions and Plug&#8217;s ability to support that transition at scale.
Andy Marsh, Plug Power&#8217;s CEO, called the agreement a clear example of the company&#8217;s industrial leadership in hydrogen technology.
Plug&#8217;s electrolyzer technology is already in use or under development across five continents, supporting industries from energy and transport to chemicals and manufacturing.
Comparable players in the clean energy space include Bloom Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) and Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>).
Investors may also follow hydrogen-related ETFs such as the Global X Hydrogen ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYDR#NASDAQ">HYDR</a>) and Defiance Next Gen H2 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HDRO#NYSE">HDRO</a>).
Price Action: PLUG shares are trading higher by 8.01% to $1.04 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45835942/self-driving-cars-may-slash-insurance-costs-50-by-2040-challenge-traditional-insurers-goldman-sachs" target="_blank" rel="noreferrer noopener">Self-Driving Cars May Slash Insurance Costs 50% By 2040, Challenge Traditional Insurers: Goldman Sachs</a></li>
</ul>
Photo via Shutterstock

Movers

ETF Series Solutions Defiance Next Gen H2 ETF

HDRO

HYDR

PLUG

Plug Power, Allied Green Expand Partnership With New Uzbekistan Deal

Press Releases

Super Group to Report Third Quarter 2024 Financial Results

Super Group Reports Financial Results for Third Quarter of 2024

Super Group Issues Business Update as 2024 Closes

Super Group Comments on Outstanding Preliminary, Unaudited, Fourth Quarter and Full-Year 2024 Performance

Super Group to Report Fourth Quarter and Full Year 2024 Financial Results

Super Group Reports Financial Results for Fourth Quarter of 2024

Super Group to Report First Quarter 2025 Financial Results

Super Group to Participate in Upcoming Investor Conferences

Super Group Reports Financial Results for First Quarter of 2025

Super Group to Host Investor Day on Thursday, September 18, 2025

SGHC

Accel Entertainment

PlayAGS

Ballys

Boyd Gaming

Codere Online Luxembourg, S.A. - Ordinary Shares

Codere Online Luxembourg

Churchill Downs, Incorporated - Common Stock

Churchill Downs

Canterbury Park Holding Corporation - Common Stock

Canterbury Park Holding

Caesars Entertainment, Inc. - Common Stock

Caesars Entertainment

DraftKings

Everi Holdings

Full House Resorts

Golden Entertainment, Inc. - Common Stock

Golden Entertainment

Genius Sports

International Game Technology Ordinary Shares

Intl Game Tech

Inspired Entertainment, Inc. - Common Stock

Inspired Entertainment

Light & Wonder

Las Vegas Sands

Monarch Casino & Resort, Inc. - Common Stock

Monarch Casino & Resort

MGM Resorts International

Melco Resorts & Entertainment Limited - American Depositary Shares

Melco Resorts and Enter

Studio City International Holdings Limited American depositary shares, each representing four Class A ordinary shares

Comments

Super Group (SGHC)

Noticias

Últimas noticias sobre Super Group (SGHC) (NYSE:SGHC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL